Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00887913 · ClinicalTrials.gov registry record · NA
Clinical Study to Evaluate the Performance of Fractional Radiofrequency for Improvement of Skin Texture Via Skin Resurfacing and Wrinkles Reduction
A NA study, sponsored by Syneron Medical.
- Completed
- Registry status
- NA
- Development phase
- 69
- Enrollment target
NCT00887913 is a NA study that has completed, run by Syneron Medical. The registered enrollment target is 69 participants.
The verdict
NCT00887913, a NA study, has completed, sponsored by Syneron Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 69 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether the Matrix RF applicator is effective in the treatment of facial skin texture and wrinkle reduction.
Interventions
- DEVICE Fractional RF treatment with Matrix RF applicator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69 participants |
| Start Date | 2008-04 |
| Est. Completion | 2009-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00887913
The ClinicalTrials.gov registry entry for NCT00887913 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 69 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Syneron Medical, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fractional RF treatment with Matrix RF applicator is the first listed.
NCT00887913 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00887913 about?
NCT00887913 is a clinical study titled "Clinical Study to Evaluate the Performance of Fractional Radiofrequency for Improvement of Skin Texture Via Skin Resurfacing and Wrinkles Reduction". The purpose of this study is to determine whether the Matrix RF applicator is effective in the treatment of facial skin texture and wrinkle reduction.
What is the current status of trial NCT00887913?
This trial is currently completed. It is a NA study. The enrollment target is 69 participants. The study started on 2008-04. Estimated completion is 2009-10.
What interventions are being tested in trial NCT00887913?
The interventions under investigation include: Fractional RF treatment with Matrix RF applicator (DEVICE).
Who is sponsoring clinical trial NCT00887913?
This trial is sponsored by Syneron Medical, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.